Abstract
[C21H28N4S2], monoclinic, P21/c (no. 14), a = 16.1880(2) Å, b = 6.8168(1) Å, c = 19.7605(2) Å, β = 106.412(1)°, V = 2091.73(5) Å3, Z = 4, Rgt(F) = 0.0281, wRref(F2) = 0.0740, T = 100(2) K.
The molecular structures of the ions are shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
Crystal: | Colourless prism |
Size: | 0.12 × 0.06 × 0.03 mm |
Wavelength: | Cu Kα radiation (1.54178 Å) |
μ: | 2.40 mm−1 |
Diffractometer, scan mode: | XtaLAB Synergy, ω |
θmax, completeness: | 67.1°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 25933, 3726, 0.035 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 3406 |
N(param)refined: | 250 |
Programs: | CrysAlisPRO [1], SHELX [2], [3], WinGX/ORTEP [4] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
S1 | 0.46765(2) | 0.26374(5) | 0.60297(2) | 0.01990(10) |
S2 | 0.58043(2) | 0.61634(5) | 0.63185(2) | 0.01875(10) |
N1 | 0.59362(7) | 0.31667(17) | 0.72131(6) | 0.0188(2) |
N2 | 0.71913(7) | 0.10047(16) | 0.82654(6) | 0.0185(2) |
N3 | 0.38889(8) | 0.63077(17) | 0.50114(6) | 0.0198(3) |
H1N | 0.4234(9) | 0.567(2) | 0.5392(7) | 0.024* |
H2N | 0.4078(10) | 0.598(2) | 0.4635(7) | 0.024* |
N4 | 0.24784(7) | 0.88689(16) | 0.43912(6) | 0.0184(2) |
C1 | 0.55113(8) | 0.39218(19) | 0.65839(7) | 0.0169(3) |
C2 | 0.66356(9) | 0.4169(2) | 0.77322(7) | 0.0209(3) |
H2A | 0.6436 | 0.4563 | 0.8142 | 0.025* |
H2B | 0.6797 | 0.5371 | 0.7519 | 0.025* |
C3 | 0.74192(9) | 0.2841(2) | 0.79802(7) | 0.0208(3) |
H3C | 0.7654 | 0.2551 | 0.7579 | 0.025* |
H3D | 0.7872 | 0.3522 | 0.8348 | 0.025* |
C4 | 0.64930(9) | 0.0005(2) | 0.77370(7) | 0.0203(3) |
H4A | 0.6333 | −0.1210 | 0.7944 | 0.024* |
H4B | 0.6697 | −0.0369 | 0.7327 | 0.024* |
C5 | 0.57100(9) | 0.1312(2) | 0.74914(7) | 0.0216(3) |
H5A | 0.5262 | 0.0632 | 0.7120 | 0.026* |
H5B | 0.5471 | 0.1582 | 0.7891 | 0.026* |
C6 | 0.78829(9) | −0.0211(2) | 0.86363(7) | 0.0193(3) |
C7 | 0.87425(10) | 0.0325(2) | 0.87526(8) | 0.0269(3) |
H7 | 0.8882 | 0.1485 | 0.8542 | 0.032* |
C8 | 0.93976(10) | −0.0823(3) | 0.91744(9) | 0.0342(4) |
H8 | 0.9980 | −0.0431 | 0.9251 | 0.041* |
C9 | 0.92162(10) | −0.2521(2) | 0.94841(9) | 0.0311(4) |
H9 | 0.9668 | −0.3285 | 0.9778 | 0.037* |
C10 | 0.83629(10) | −0.3096(2) | 0.93600(8) | 0.0246(3) |
H10 | 0.8230 | −0.4270 | 0.9566 | 0.029* |
C11 | 0.77049(9) | −0.1967(2) | 0.89382(7) | 0.0206(3) |
H11 | 0.7125 | −0.2388 | 0.8852 | 0.025* |
C12 | 0.29823(9) | 0.5647(2) | 0.48794(8) | 0.0248(3) |
H12A | 0.2787 | 0.5888 | 0.5304 | 0.030* |
H12B | 0.2943 | 0.4221 | 0.4781 | 0.030* |
C13 | 0.24121(9) | 0.6745(2) | 0.42592(8) | 0.0230(3) |
H13A | 0.2586 | 0.6440 | 0.3829 | 0.028* |
H13B | 0.1807 | 0.6322 | 0.4179 | 0.028* |
C14 | 0.33664(9) | 0.9518(2) | 0.44995(8) | 0.0220(3) |
H14A | 0.3405 | 1.0951 | 0.4585 | 0.026* |
H14B | 0.3548 | 0.9247 | 0.4071 | 0.026* |
C15 | 0.39576(9) | 0.8458(2) | 0.51244(8) | 0.0233(3) |
H15A | 0.4560 | 0.8880 | 0.5187 | 0.028* |
H15B | 0.3799 | 0.8799 | 0.5559 | 0.028* |
C16 | 0.18218(9) | 1.0003(2) | 0.39213(7) | 0.0190(3) |
C17 | 0.09633(9) | 0.9579(2) | 0.38733(8) | 0.0239(3) |
H17 | 0.0833 | 0.8529 | 0.4142 | 0.029* |
C18 | 0.02996(10) | 1.0662(2) | 0.34405(8) | 0.0280(3) |
H18 | −0.0280 | 1.0340 | 0.3411 | 0.034* |
C19 | 0.04749(10) | 1.2218(2) | 0.30483(8) | 0.0305(4) |
H19 | 0.0020 | 1.2968 | 0.2753 | 0.037* |
C20 | 0.13211(11) | 1.2654(2) | 0.30958(9) | 0.0302(3) |
H20 | 0.1447 | 1.3716 | 0.2830 | 0.036* |
C21 | 0.19972(10) | 1.1564(2) | 0.35278(8) | 0.0242(3) |
H21 | 0.2576 | 1.1887 | 0.3553 | 0.029* |
Source of material
All chemicals and solvents were used as purchased without purification. The melting point was determined using a Mel-temp II digital melting point apparatus and was uncorrected. The solid-state IR spectrum was obtained on a Bruker Vertex 70v FTIR Spectrometer from 4000 to 400 cm−1. The 1H and 13C{1H} NMR spectra were recorded at room temperature in CDCl3 solution on a Bruker Ascend 400 MHz NMR spectrometer with chemical shifts relative to tetramethylsilane.
The dithiocarbamate ligand was prepared in situ (methanol) from the reaction of CS2 (Merck, 0.25 mmol) with 1-phenylpiperazine (Aldrich, 0.25 mmol) and NaOH (0.02 mL; 50% w/v); CS2 was added dropwise into the methanol solution (10 mL). The resulting mixture solution was kept at 273 K for 1 h. The filtrate was evaporated until a beige precipitate was obtained. The precipitate was washed with n-hexane and recrystallised from a methanol-acetone solution to furnish colourless crystals. Yield: 0.010 g (10.0%). M.pt: 441–443 K. IR (cm−1) 1597 (m) ν(C—N), 1580 (m) ν(C—N), 1491 (m) ν(C—N), 1012 (s) ν(C—S), 756 (m) ν(C—S). 1H NMR (CDCl3, ppm): δ 3.16-3.29 (m, 8H, N-CH2), 4.45-4.60 (m, 8H, N-CH2), 6.86-6.94, 7.23-7.32 (m, 10H, Ph-H). 13C{1H} NMR (CDCl3, ppm): δ 45.7, 49.8 (N-CH2), 116.3, 120.1, 129.2, 150.1 (Ph-C), 193.7 (CS2).
Experimental details
The C-bound H atoms were geometrically placed (C—H =0.95–0.99 Å) and refined as riding with Uiso(H) = 1.2Ueq(C). The N-bound H-atoms were located in a difference Fourier map but were refined with a distance restraint N—H = 0.91 ± 0.01 Å, and with Uiso(H) set to 1.2Ueq(N).
Comment
The title salt of a dithiocarbamate ligand (−S2CNRR’) became available during the course of methodical studies evaluating the structural chemistry of the homoleptic zinc-triad dithiocarbamates [5] and their adducts with bipyridyl-type ligands aimed for the construction of coordination polymers [6]. In this context, and underscoring the importance of systematic evaluations of closely related compounds, recent work on functionalised dithiocarbamates, i.e. homoleptic morpholinodithiocarbamates, revealed a hitherto unobserved structural motif for cadmium dithiocarbamates [7], namely a linear coordination polymer with hexa-coordinated cadmium centres, {Cd[S2CN(CH2CH2)2O]2}n, although the binuclear zinc(II) structure of the same ligand, {Zn[S2CN(CH2CH2)2O]2}2, adopted the usual structural motif [5]; precendents for the linear coordination polymer motif are evident in related xanthate (−S2COR) structures [8]. The presence of substituents capable of hydrogen bonding interactions in the dithiocarbamate ligands are also thought important for enhancing the biological activity of metal compounds of this potentially important class of ligands [9]. Current work in this context focuses on the exciting anti-bacterial activity exhibited by gold(I) dithiocarbamates [10], [11]. Herein, the crystal and molecular structures of the title salt, [PhN(CH2CH2)2NH2][S2CN(CH2CH2)2NPh], are described.
The constituents of the title salt are shown in the figure (70% displacement ellipsoids); the asymmetric unit comprises a 4-phenylpiperazin-1-ium cation and a (4-phenylpiperazin-1-yl)dithiocarbamate anion. The confirmation for this formulation is revealed in the pattern of hydrogen bonding exhibited by the piperazin-1-ium-N—H atoms (see below). Further, the C—N3 bond lengths [C12—N3 = 1.4861(19) Å and C15—N3 = 1.4822(18) Å] are systematically longer than the C–N4 bonds [C13—N4 = 1.4694(18) Å and C14—N4 = 1.4609(18) Å]. The piperazin-1-ium ring has a chair conformation.
In the anion, the piperazin-1-yl ring also has a chair conformation. Further support for the formation of a salt is seen in the experimental equivalence of the C1—S1, S2 bond lengths [C1—S1 = 1.7192(14) Å and C1—S2 = 1.7249(14) Å]. As anticipated, the C1—N1 bond length [1.3419(18) Å] is considerably shorter than the C2—N1 [1.4643(17) Å] and C5—N1 [1.4660(17) Å] bond lengths, an observation consistent with a significant contribution of the 2−S2C=N+(CH2CH2)2NPh canonical form to the overall electronic structure of the S2CN chromophore in the anion. Reflecting the equivalence of the C—S bonds, the S1—C1—N1 and S2—C1—N2 bond angles are equivalent [119.98(10) and 120.57(10)°, respectively] with S1—C1—S2 angle being very similar [119.45(8)°], observations consistent with a regular trigonal geometry about the C1 atom. This regular geometry contrasts the observations in the recently reported dithiocarbamate ester, MeSC(=S)N(Me)Ph [12], whereby the bond angles involving the thione-sulphur atom were approximately 10° wider [i.e. 123.47(11) and 123.32(13)°] than the angle involving the singly-bound sulphur atom and nitrogen [113.21(13)°].
The only prominent supramolecular contacts in the molecular packing are charge-assisted 4-phenylpiperazin-1-ium-N—H⋯S(dithiocarbamate) hydrogen bonds disposed about a centre of inversion [N3—H1n⋯S1: H1n⋯S1 = 2.422(14) Å, N3⋯S1 = 3.2380(12) Å with angle at H1n = 149.3(12)° and N3—H2n⋯S2i: H2n⋯S2i = 2.434(14) Å, N3⋯S2i = 3.2753(12) Å with angle at H2n = 154.1(13)° for symmetry operation (i) 1 = x, 1 = y, 1 = z]. As shown in the lower view of the figure, these interactions lead to a four-ion aggregate sustained by a 12-membered {⋯HNH⋯SCS}2 synthon with a distinctive kinked conformation. The relatively large deviations from linearity of the N—H⋯S hydrogen bonds are readily explained by transannular interactions within the aggregate as seen in the H1n⋯S2 and H2n⋯S1i separations of 2.701(14) and 2.859(16) Å, respectively.
To analyse the molecular packing of the four-molecule aggregates in more detail, Crystal Explorer 17 [13] was utilised to calculate the Hirshfeld surface, following standard procedures [14]; herein, the Hirshfeld surfaces as well as the overall and delineated two-dimensional fingerprint plots were evaluated. The most dominant contacts contributing to the surface are H⋯H contacts, at 61.4%, entirely consistent with the lack of directional interactions connecting the four-molecule aggregates. The next most prominent contacts are of the type C⋯H/H⋯C [20.6%], S⋯H/H⋯S [14.2%] and N⋯H/H⋯N [3.0%].
Acknowledgements
Sunway University Sdn Bhd is thanked for financial support of this work through Grant no. STR-RCTR-RCCM-001-2019.
References
1. Rigaku Oxford Diffraction: CrysAlisPRO. Rigaku Corporation, Oxford, UK (2018).Suche in Google Scholar
2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed
3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central
4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Suche in Google Scholar
5. Tiekink, E. R. T.: Exploring the topological landscape exhibited by binary zinc-triad 1,1-dithiolates. Crystals 8 (2018) 292.10.3390/cryst8070292Suche in Google Scholar
6. Tiekink, E. R. T.: Perplexing coordination behaviour of potentially bridging bipyridyl-type ligands in the coordination chemistry of zinc and cadmium 1,1-dithiolate compounds. Crystals 8 (2018) 18.10.3390/cryst8010018Suche in Google Scholar
7. Ahmad, J.; How, F. N.-F.; Halim, S. N. A.; Jotani, M. M.; Lee, S. M.; Tiekink, E. R. T.: A new structural motif for cadmium dithiocarbamates: crystal structures and Hirshfeld surface analyses of homoleptic zinc and cadmium morpholine dithiocarbamates. Z. Kristallogr. – Cryst. Mater. 234 (2019) 341–349.10.1515/zkri-2018-2141Suche in Google Scholar
8. Tiekink, E. R. T.; Haiduc, I.: Stereochemical aspects of metal xanthate complexes: molecular structures and supramolecular self-assembly. Prog. Inorg. Chem. 54 (2005) 127–319.10.1002/0471725560.ch3Suche in Google Scholar
9. Hogarth, G.: Metal-dithiocarbamate complexes: chemistry and biological activity. Mini Rev. Med. Chem. 12 (2012) 1202–1215.10.2174/138955712802762095Suche in Google Scholar PubMed
10. Chen, B.-J.; Jamaludin, N. S.; Khoo, C.-H.; See, T.-H.; Sim, J.-H.; Cheah, Y.-K.; Halim, S. N. A.; Seng, H.-L.; Tiekink, E. R. T.: In vitro antibacterial and time kill evaluation of mononuclear phosphanegold(I) dithiocarbamates. J. Inorg. Biochem. 163 (2016) 68–80.10.1016/j.jinorgbio.2016.08.002Suche in Google Scholar PubMed
11. Tan, Y. J.; Tan, Y. S.; Yeo, C. I.; Chew, J.; Tiekink, E. R. T.: In vitro anti-bacterial and time kill evaluation of binuclear tricyclohexylphosphanesilver(I) dithiocarbamates, {Cy3PAg(S2CNRR’)}2. J. Inorg. Biochem. 192 (2019) 107–118.10.1016/j.jinorgbio.2018.12.017Suche in Google Scholar PubMed
12. Lo, K. M.; Lee, S. M.; Tiekink, E. R. T.: Crystal structure of N-methyl-N-phenyl(methylsulfanyl) carbothioamide, C9H11NS2. Z. Kristallogr. NCS 234 (2019) nrcs-2019-5011.10.1515/ncrs-2019-0511Suche in Google Scholar
13. Turner, M. J.; McKinnon, J. J.; Wolff, S. K.; Grimwood, D. J.; Spackman, P. R.; Jayatilaka, D.; Spackman, M. A.: Crystal Explorer v17. The University of Western Australia, Australia (2017).Suche in Google Scholar
14. Tan, S. L.; Jotani, M. M.; Tiekink, E. R. T.: Utilizing Hirshfeld surface calculations, non-covalent interaction (NCI) plots and the calculation of interaction energies in the analysis of molecular packing. Acta Crystallogr. E75 (2019) 308–318.10.1107/S2056989019001129Suche in Google Scholar PubMed PubMed Central
©2019 Kong Mun Lo et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 Public License.
Artikel in diesem Heft
- Frontmatter
- Crystal structure of [aqua[2,2′-(1,2-phenylene)bis(1H-imidazole-4-carboxylato-5-carboxy)-κ4N3,N3′,O4,O4′] zinc(II)] monohydrate, C16H10N4O9Zn⋅H2O
- Crystal structure of ethyl 3-(4-methoxyphenyl)-5-methylcarbamoyl-1H-pyrazole-4-carboxylate, C15H17N3O4
- 7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-N-phenyl-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbothioamide–dimethylformamide (2/1), C27H23F2N3S, 0.5(C3H7NO)
- Crystal structure of 4,4′-(hydrazonomethylene)diphenol dihydrate, C13H16N2O4
- Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
- Crystal Structure of tris(tetrakis{1-vinyl-1H-imidazole-κN}copper(II)) bis[tri-μ2-bromido-tetrabromido-bis(1-vinyl-1H-imidazole-κN)tetracopper(I)], C80H96N32Cu11Br14
- Crystal structure of (E)-2-(3,6-bis(diethylamino)-9H-xanthen-9-yl)-N′-(quinoxalin-2-ylmethylene)benzohydrazide, C37H36N6O2
- Crystal structure of 4-(1-phenylimidazo[1,5-a]pyridin-3-yl)benzoic acid (C20H14N2O2)
- Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
- Crystal structure of dimethyl 3,12-dibenzyl-6,10-diphenyl-3,12-diazapentacyclo [6.3.1.02.7.04.11.05.9]-dodecane-7,11-dicarboxylate — acetone (2/1), C40H38N2O2 ⋅ 0.5C3H6O
- Crystal structure of poly[(μ2-2-(1H-1,2,4-triazol-1-yl)benzoato-κ4O:O′:N:N′)silver(I)] monohydrate, C9H8AgO3N3
- Crystal structure of poly[(μ2-9H-carbazole-3,6-dicarboxylate-κ4O1,O2:O3,O4)(μ2-1,3-di(pyridin-4-yl)propane-κ2N:N′)cadmium(II)]monohydrate, C27H23N3O5Cd
- The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir
- The crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfonyl)-1H-pyrazole-3-carboxamide, C12H6N4Cl2F6O3S
- Synthesis and crystal structure of poly[(μ2-nitrato-κ4O,O′:O′,O′′)-nitrato-κO-(μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)cadmium(II)], C14H14N6O6Cd
- Crystal structure of ethyl (Z)-(4-oxo-4-phenylbut-2-en-2-yl)glycinate, C14H17NO3
- Halogen bonds in the crystal structure of 5-bromo-3,4′-bipyridine – 1,4-diiodotetrafluorobenzene (2/1), C26H14Br2F4I2N4
- Crystal structure of bis(2,2′-bipyridine-κ2N,N′)-tetrakis(μ2-3-(phenylsulfonamido)propanoato-κ2O:O′)-bis(3-(phenylsulfonamido)propanoato-κ2O,O′)digadolinium(III) – 2,2′-bipyridine (1/1), C84H84Gd2N12O24S6
- Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ2O:O′)bis(μ2-pyrazin-κ2N:N′)silver(I)], C14H16Ag2N5O8S2
- The crystal structure of 1,6-di-tert-butyl-1,1,3,3,4,4,6,6-octamethyl-2,2,5,5-tetrakis (trimethylsilyl)hexasilane, C28H78Si10
- Crystal structure of discandium triruthenium tetrasilicide, Sc2Ru3Si4
- Crystal structure of poly[(μ2-4-amino-1,5-naphthalenedisulfonato-κ4O,N:O′, N′)bis(μ2-hexamethylenetetramino-κ2N;N′)silver(I)], {C22H30Ag2N9O6S2}n
- Crystal structure of diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-κ4O,O′,N,N′)]zinc(II) dihydrate, C13H18N4O12Zn
- The crystal structure of poly [(μ3-N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide-κ3-O:N:N′)-(p-toluenesulfonato-κ2O,O′)silver(I)], C25H27Ag1N4O5S
- The crystal structure of 1,2-bis(3-bromophenoxy) ethane, C14H12Br2O2
- The crystal structure of 4-(pyren-1-yl)butyl-3-nitrobenzoate, C27H21NO4
- Crystal structure of bis[(2-(4-chlorophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ1O) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Cl2N4NiO8
- The crystal structure of 1,5-dinitro-2,3,4-trichlorobenzene, C6H1Cl3N2O4
- The crystal structure of the solid solution of 3,5-dinitropyrazole and 4-chlorine-3,5-dinitropyrazole, C3H1.24Cl0.76N4O4
- The cocrystal structure of 4-nitropyrazole — acetic acid (1/1), C5H7N3O4
- The crystal structure of propan-2-one O-(2,4,6-trinitrophenyl) oxime, C9H8N4O7
- The crystal structure of ethyl 2-(3-(2-ethoxy-2-oxoethyl)benzo[d] thiazol-2(3H)-ylidene)acetate, C15H17NO4S
- Crystal structure of (acetic acid-κ1O)-bis(μ2-2-chlorobenzoato-κ2O:O′)-(2-chlorobenzoato-κ1O)-(μ2-hydroxy-κ2O:O)-bis(1,10-phenanthroline-κ2N,N′)dimanganese(II) — methanol (1/1), C48H37Cl3Mn2N4O10
- Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
- Crystal structure of chlorido-(5-acetyl-2-(5-methylpyridin-2-yl)benzen-1-ido-κ2C,N)-pyridine-κN-palladium(II), C19H17ClN2OPd
- Crystal structure of (4-methyl-benzoato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C24H45ClN4NiO7
- Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) 1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl(potassium, rubidium) — ammonia (1/2), [K0.3Rb0.7(18-crown-6)]Cp*⋅2 NH3, C22H45K0.3N2O6Rb0.7
- Crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3-nitrobenzylidene)piperidin-4-one — dichloromethane (2/1), C51H38Cl2F2N6O14S2
- Crystal structure of (E)-N′-((1,6-dihydropyren-1-yl)methylene)isonicotinohydrazide — methanol (1/1), C24H19N3O2
- Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ3N,O:O′)-(μ4-hexamethylenetetramino-κ4N:N′:N′′:N′′′)disilver(I)] monohydrate, C12H21Ag2N5O8S2
- Crystal structure of bis(acridin-10-ium) 2,5-dihydroxyterephthalate — 2,5-dihydroxyterephthalic acid (1/1), C21H15NO6
- The crystal structure of 1,12-diazaperylene, C18H10N2
- Crystal structure of 1-(5-(4-chlorophenyl)-3-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one, C17H14N2OFCl
- Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
- The crystal structure of tetrachlorido-bis{1,3-bis(2,6-diisopropylphenyl)-1H-3λ4-imidazol-2-yl}-(μ2-pyrimidine-κ2N:N′)dipalladium(IV) — dichloromethane (1/2), C60H80Cl8N6Pd2
- The crystal structure of (E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-yl 4-nitrobenzoate, C22H19NO7
- Crystal structure of 3-methyl-N-(pyrimidin-5-ylmethyl)pyridin-2-amine, C11H12N4
- The crystal structure of 2,5-dichloroterephthalic acid dihydrate, C8H8Cl2O6
- The crystal structure of 2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine — dimethylformamide (1/1), C33H28N10O
- Crystal structure of N-(adamantan-1-yl)-5-(dimethylamino)naphthalene-1-sulfonamide, C22H28N2O2S
- Crystal structure of poly[diaqua-(μ4-4-(3,5-dicarboxy-κ1O-phenoxy)phthalato-κ3O:O′:O′)cadmium(II)], C16H12CdO11
- Crystal structure of poly[diaqua-bis(μ2-3-((1H-imidazol-1-yl)methyl)benzoato-κ2N:O)manganese(II)], C22H22MnN4O6
- Crystal structure of 9-(3-phenoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione, C25H23NO3
- The crystal structure of poly[(μ3-2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine-k3N:N′:N′′)-(nitrato-k2O,O)-(nitrato-k1O)zinc(II)] - N,N-dimethylacetamide (1/2), C38H39N13O8Zn
- Crystal structure of poly[(μ7-4-(3,5-dicarboxylatophenoxy)phthalato)-(1,10-phenanthroline-κ2N,N′)dizinc(II)], C28H14N2O9Zn2
- The crystal structure of methyl 2-(benzylamino)-5-(benzyloxy)benzoate, C22H21NO3
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanoplatinate(II), C14H24N8PdPt
- Crystal structure of (pyridine-2-carboxylato-κ2N,O)-[2-(2-pyridyl)phenyl-κ2N,C1]palladium(II), C17H12N2O2Pd
- Crystal structure of (cyclohexane-1,4-diammonium) 4-[(4-carboxylatophenyl)disulfanyl]benzoate dimethylsulphoxide hydrate (1/1/1/1), [C6H16N2]2+[C14H8O4S2]2−⋅C2H6OS⋅H2O
- Crystal structure of the 2:1 co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-bromobenzoic acid, 2(C14H10O4S2)⋅C7H5BrO2
- Crystal structure of chlorido-dimethyl-(phenylpiperazine-1-carbodithioato-κ2S,S′)tin(IV), C13H19ClN2S2Sn
- Crystal structure of (N-n-butyl, N-methyl-dithiocarbamato-κ2 S,S′)-chlorido-dimethyl-tin(IV), C8H18ClNS2Sn
- Crystal structure of (2,2′-bipyridyl)bis(4-bromobenzyl)dibromidotin(IV), C24H20Br4N2Sn
- Crystal structure of (2,2′-bipyridyl)bis(4-chlorobenzyl)dichloridotin(IV), C24H20Cl4N2Sn
- Crystal structure of N-methyl-N-phenyl(methylsulfanyl)carbothioamide, C9H11NS2
- Crystal structure of 4-phenylpiperazin-1-ium (4-phenylpiperazin-1-yl)carbothioylsulfanide, [C10H15N2][C11H13N2S2]
- Crystal structure of catena-{di-aqua-sodium [n-butyl(methyl)carbamothioyl]sulfanide}n, [C6H16NNaO2S2]n
- Crystal structure of (2-([1,1-bis(hydroxymethyl)-2-oxyethyl]iminomethyl)-5-(n-decyl)phenolato)-dimethyl-tin(IV), C23H39NO5Sn
- Crystal structure of 4-chloro-N′-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]benzohydrazide – a Z′ = 3 structure, C16H15ClN2O3
Artikel in diesem Heft
- Frontmatter
- Crystal structure of [aqua[2,2′-(1,2-phenylene)bis(1H-imidazole-4-carboxylato-5-carboxy)-κ4N3,N3′,O4,O4′] zinc(II)] monohydrate, C16H10N4O9Zn⋅H2O
- Crystal structure of ethyl 3-(4-methoxyphenyl)-5-methylcarbamoyl-1H-pyrazole-4-carboxylate, C15H17N3O4
- 7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-N-phenyl-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbothioamide–dimethylformamide (2/1), C27H23F2N3S, 0.5(C3H7NO)
- Crystal structure of 4,4′-(hydrazonomethylene)diphenol dihydrate, C13H16N2O4
- Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
- Crystal Structure of tris(tetrakis{1-vinyl-1H-imidazole-κN}copper(II)) bis[tri-μ2-bromido-tetrabromido-bis(1-vinyl-1H-imidazole-κN)tetracopper(I)], C80H96N32Cu11Br14
- Crystal structure of (E)-2-(3,6-bis(diethylamino)-9H-xanthen-9-yl)-N′-(quinoxalin-2-ylmethylene)benzohydrazide, C37H36N6O2
- Crystal structure of 4-(1-phenylimidazo[1,5-a]pyridin-3-yl)benzoic acid (C20H14N2O2)
- Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
- Crystal structure of dimethyl 3,12-dibenzyl-6,10-diphenyl-3,12-diazapentacyclo [6.3.1.02.7.04.11.05.9]-dodecane-7,11-dicarboxylate — acetone (2/1), C40H38N2O2 ⋅ 0.5C3H6O
- Crystal structure of poly[(μ2-2-(1H-1,2,4-triazol-1-yl)benzoato-κ4O:O′:N:N′)silver(I)] monohydrate, C9H8AgO3N3
- Crystal structure of poly[(μ2-9H-carbazole-3,6-dicarboxylate-κ4O1,O2:O3,O4)(μ2-1,3-di(pyridin-4-yl)propane-κ2N:N′)cadmium(II)]monohydrate, C27H23N3O5Cd
- The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir
- The crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfonyl)-1H-pyrazole-3-carboxamide, C12H6N4Cl2F6O3S
- Synthesis and crystal structure of poly[(μ2-nitrato-κ4O,O′:O′,O′′)-nitrato-κO-(μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)cadmium(II)], C14H14N6O6Cd
- Crystal structure of ethyl (Z)-(4-oxo-4-phenylbut-2-en-2-yl)glycinate, C14H17NO3
- Halogen bonds in the crystal structure of 5-bromo-3,4′-bipyridine – 1,4-diiodotetrafluorobenzene (2/1), C26H14Br2F4I2N4
- Crystal structure of bis(2,2′-bipyridine-κ2N,N′)-tetrakis(μ2-3-(phenylsulfonamido)propanoato-κ2O:O′)-bis(3-(phenylsulfonamido)propanoato-κ2O,O′)digadolinium(III) – 2,2′-bipyridine (1/1), C84H84Gd2N12O24S6
- Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ2O:O′)bis(μ2-pyrazin-κ2N:N′)silver(I)], C14H16Ag2N5O8S2
- The crystal structure of 1,6-di-tert-butyl-1,1,3,3,4,4,6,6-octamethyl-2,2,5,5-tetrakis (trimethylsilyl)hexasilane, C28H78Si10
- Crystal structure of discandium triruthenium tetrasilicide, Sc2Ru3Si4
- Crystal structure of poly[(μ2-4-amino-1,5-naphthalenedisulfonato-κ4O,N:O′, N′)bis(μ2-hexamethylenetetramino-κ2N;N′)silver(I)], {C22H30Ag2N9O6S2}n
- Crystal structure of diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-κ4O,O′,N,N′)]zinc(II) dihydrate, C13H18N4O12Zn
- The crystal structure of poly [(μ3-N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide-κ3-O:N:N′)-(p-toluenesulfonato-κ2O,O′)silver(I)], C25H27Ag1N4O5S
- The crystal structure of 1,2-bis(3-bromophenoxy) ethane, C14H12Br2O2
- The crystal structure of 4-(pyren-1-yl)butyl-3-nitrobenzoate, C27H21NO4
- Crystal structure of bis[(2-(4-chlorophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ1O) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Cl2N4NiO8
- The crystal structure of 1,5-dinitro-2,3,4-trichlorobenzene, C6H1Cl3N2O4
- The crystal structure of the solid solution of 3,5-dinitropyrazole and 4-chlorine-3,5-dinitropyrazole, C3H1.24Cl0.76N4O4
- The cocrystal structure of 4-nitropyrazole — acetic acid (1/1), C5H7N3O4
- The crystal structure of propan-2-one O-(2,4,6-trinitrophenyl) oxime, C9H8N4O7
- The crystal structure of ethyl 2-(3-(2-ethoxy-2-oxoethyl)benzo[d] thiazol-2(3H)-ylidene)acetate, C15H17NO4S
- Crystal structure of (acetic acid-κ1O)-bis(μ2-2-chlorobenzoato-κ2O:O′)-(2-chlorobenzoato-κ1O)-(μ2-hydroxy-κ2O:O)-bis(1,10-phenanthroline-κ2N,N′)dimanganese(II) — methanol (1/1), C48H37Cl3Mn2N4O10
- Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
- Crystal structure of chlorido-(5-acetyl-2-(5-methylpyridin-2-yl)benzen-1-ido-κ2C,N)-pyridine-κN-palladium(II), C19H17ClN2OPd
- Crystal structure of (4-methyl-benzoato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C24H45ClN4NiO7
- Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) 1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl(potassium, rubidium) — ammonia (1/2), [K0.3Rb0.7(18-crown-6)]Cp*⋅2 NH3, C22H45K0.3N2O6Rb0.7
- Crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3-nitrobenzylidene)piperidin-4-one — dichloromethane (2/1), C51H38Cl2F2N6O14S2
- Crystal structure of (E)-N′-((1,6-dihydropyren-1-yl)methylene)isonicotinohydrazide — methanol (1/1), C24H19N3O2
- Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ3N,O:O′)-(μ4-hexamethylenetetramino-κ4N:N′:N′′:N′′′)disilver(I)] monohydrate, C12H21Ag2N5O8S2
- Crystal structure of bis(acridin-10-ium) 2,5-dihydroxyterephthalate — 2,5-dihydroxyterephthalic acid (1/1), C21H15NO6
- The crystal structure of 1,12-diazaperylene, C18H10N2
- Crystal structure of 1-(5-(4-chlorophenyl)-3-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one, C17H14N2OFCl
- Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
- The crystal structure of tetrachlorido-bis{1,3-bis(2,6-diisopropylphenyl)-1H-3λ4-imidazol-2-yl}-(μ2-pyrimidine-κ2N:N′)dipalladium(IV) — dichloromethane (1/2), C60H80Cl8N6Pd2
- The crystal structure of (E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-yl 4-nitrobenzoate, C22H19NO7
- Crystal structure of 3-methyl-N-(pyrimidin-5-ylmethyl)pyridin-2-amine, C11H12N4
- The crystal structure of 2,5-dichloroterephthalic acid dihydrate, C8H8Cl2O6
- The crystal structure of 2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine — dimethylformamide (1/1), C33H28N10O
- Crystal structure of N-(adamantan-1-yl)-5-(dimethylamino)naphthalene-1-sulfonamide, C22H28N2O2S
- Crystal structure of poly[diaqua-(μ4-4-(3,5-dicarboxy-κ1O-phenoxy)phthalato-κ3O:O′:O′)cadmium(II)], C16H12CdO11
- Crystal structure of poly[diaqua-bis(μ2-3-((1H-imidazol-1-yl)methyl)benzoato-κ2N:O)manganese(II)], C22H22MnN4O6
- Crystal structure of 9-(3-phenoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione, C25H23NO3
- The crystal structure of poly[(μ3-2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine-k3N:N′:N′′)-(nitrato-k2O,O)-(nitrato-k1O)zinc(II)] - N,N-dimethylacetamide (1/2), C38H39N13O8Zn
- Crystal structure of poly[(μ7-4-(3,5-dicarboxylatophenoxy)phthalato)-(1,10-phenanthroline-κ2N,N′)dizinc(II)], C28H14N2O9Zn2
- The crystal structure of methyl 2-(benzylamino)-5-(benzyloxy)benzoate, C22H21NO3
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanoplatinate(II), C14H24N8PdPt
- Crystal structure of (pyridine-2-carboxylato-κ2N,O)-[2-(2-pyridyl)phenyl-κ2N,C1]palladium(II), C17H12N2O2Pd
- Crystal structure of (cyclohexane-1,4-diammonium) 4-[(4-carboxylatophenyl)disulfanyl]benzoate dimethylsulphoxide hydrate (1/1/1/1), [C6H16N2]2+[C14H8O4S2]2−⋅C2H6OS⋅H2O
- Crystal structure of the 2:1 co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-bromobenzoic acid, 2(C14H10O4S2)⋅C7H5BrO2
- Crystal structure of chlorido-dimethyl-(phenylpiperazine-1-carbodithioato-κ2S,S′)tin(IV), C13H19ClN2S2Sn
- Crystal structure of (N-n-butyl, N-methyl-dithiocarbamato-κ2 S,S′)-chlorido-dimethyl-tin(IV), C8H18ClNS2Sn
- Crystal structure of (2,2′-bipyridyl)bis(4-bromobenzyl)dibromidotin(IV), C24H20Br4N2Sn
- Crystal structure of (2,2′-bipyridyl)bis(4-chlorobenzyl)dichloridotin(IV), C24H20Cl4N2Sn
- Crystal structure of N-methyl-N-phenyl(methylsulfanyl)carbothioamide, C9H11NS2
- Crystal structure of 4-phenylpiperazin-1-ium (4-phenylpiperazin-1-yl)carbothioylsulfanide, [C10H15N2][C11H13N2S2]
- Crystal structure of catena-{di-aqua-sodium [n-butyl(methyl)carbamothioyl]sulfanide}n, [C6H16NNaO2S2]n
- Crystal structure of (2-([1,1-bis(hydroxymethyl)-2-oxyethyl]iminomethyl)-5-(n-decyl)phenolato)-dimethyl-tin(IV), C23H39NO5Sn
- Crystal structure of 4-chloro-N′-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]benzohydrazide – a Z′ = 3 structure, C16H15ClN2O3